Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Eli Lilly Corp. | 42 | 0 | 3 | 0 | €699.50 | €751.76 | 7.471% |
Biogen Inc. | 42 | 0 | 3 | 0 | €202.00 | €298.07 | 47.561% |
Vertex Pharmaceuticals Inc. | 36 | 2 | 2 | 0 | €378.90 | €379.70 | 0.210% |
Alnylam Pharmace. | 33 | 0 | 4 | 0 | €137.20 | €244.30 | 78.058% |
Intuitive Surgical Inc | 33 | 0 | 3 | 0 | €362.45 | €366.64 | 1.156% |
Boston Scientific | 33 | 0 | 0 | 0 | €61.86 | €58.88 | -4.820% |
Regeneron Pharmaceuticals Inc. | 31 | 1 | 3 | 0 | €883.00 | €932.90 | 5.651% |
Johnson & Johnson | 30 | 0 | 3 | 0 | €144.40 | €196.36 | 35.983% |
UnitedHealth Group Inc. | 28 | 1 | 1 | 0 | €450.00 | €546.89 | 21.531% |
Pfizer Inc. | 27 | 3 | 3 | 0 | €25.55 | €40.66 | 59.137% |
Merck & Co. Inc. | 25 | 1 | 1 | 1 | €111.60 | €124.47 | 11.532% |
Thermo Fisher Scientific Inc. | 23 | 0 | 0 | 0 | €532.40 | €558.84 | 4.966% |
Cytokinetics Inc. | 23 | 1 | 5 | 0 | €59.00 | €80.35 | 36.185% |
Trinity Biotech ADR | 21 | 0 | 1 | 0 | €0.41 | - | - |
Edwards Lifesciences Corp. | 21 | 1 | 0 | 0 | €85.48 | €87.81 | 2.722% |
Amgen Inc. | 20 | 0 | 0 | 0 | €250.00 | €291.23 | 16.493% |
Tenet Healthcare | 20 | 0 | 1 | 0 | €92.50 | €91.18 | -1.427% |
Intra-Cellular Therapies Inc. | 19 | 0 | 4 | 0 | €60.20 | €75.68 | 25.711% |
Neurocrine Bioscience | 19 | 0 | 2 | 0 | €129.15 | €136.01 | 5.314% |
Zoetis Inc. A | 19 | 0 | 1 | 0 | €157.90 | €200.06 | 26.699% |
BioMarin Pharmaceutical Inc. | 18 | 0 | 2 | 0 | €76.88 | €102.48 | 33.293% |
R1 RCM Inc. | 17 | 0 | 6 | 0 | €12.00 | €17.21 | 43.438% |
Pro-Dex Inc. | 17 | 0 | 0 | 0 | €15.30 | - | - |
Iovance Biotherapeutics Inc. | 19 | 2 | 7 | 0 | €12.76 | €25.20 | 97.514% |
HCA Holdings Inc. | 17 | 0 | 1 | 0 | €301.00 | €294.53 | -2.151% |